The effect of processing parameters on the microstructure and mechanical properties of low-Si transformation-induced plasticity steels

A base low Si, high-Al transformation-induced plasticity (TRIP) steel and one with 0.03Nb and 0.02Ti (wt%) additions were subjected to thermo-mechanical processing (TMP) and galvanising simulations. The microstructure and mechanical properties were analysed using a combination of optical and electron microscopy, X-ray diffraction and tensile testing and the results compared with those from intercritically annealed-galvanised steels. The addition of Nb and Ti results in microstructure refinement and an increase in the amount of the retained austenite after TMP which in turn, leads to increases in the tensile strength (similar to 750 MPa) and the total elongation (TE) (similar to 29 %). A deterioration in the volume fraction of retained austenite and the mechanical properties was noted in both steels after the additional galvanising simulation. For the base steel, all TMP and galvanised samples presented with continuous yielding during tensile testing. The Nb-Ti steel exhibited discontinuous yielding and extended Luders banding when TMP was followed by a longer coiling time. Both steels returned discontinuous yielding after the intercritical annealing-galvanising treatment. The discontinuous yielding behaviour was associated with the much finer ferrite grain size in the intercritically annealed steels and the ageing processes that take place during galvanising.X1166sciescopu

Efficacy of 5-Nitroimidazoles for the Treatment of Giardiasis: A Systematic Review of Randomized Controlled Trials

BACKGROUND: Giardiasis is one of the most common causes of diarrheal disease worldwide and 5-nitroimidazoles (5-NI) are the most commonly prescribed drugs for the treatment of giardiasis. We evaluated the efficacy of 5-nitroimidazoles (5-NI) in the treatment of giardiasis in a systematic review of randomized controlled trials (RCTs). METHODOLOGY/PRINCIPAL FINDINGS: We conducted a comprehensive literature search in PubMed-Medline, Scopus, Web of Science and Cochrane Library for RCTs evaluating the efficacy of 5-NI vs. control (placebo or active treatment) on parasitological cure in patients with parasitologically-demonstrated giardiasis. The search was performed in May 2013 with no language restriction by two authors independently. The efficacy outcome was parasitological cure, and harmful outcomes were abdominal pain, bitter or metallic taste, and headache. We included 30 RCTs (n = 3,930). There was a significant and slightly higher response rate with 5-NI in giardiasis treatment (RR 1.06, 95%CI 1.02–1.11, p = 0.005). There was high heterogeneity among studies (I(2) = 72%). The response rates for metronidazole, tinidazole and secnidazole were similar (RR 1.05, 95%CI 1.01–1.09, p = 0.01; RR 1.32 95%CI 1.10–1.59, p = 0.003; and RR 1.18 95%CI 0.93–1.449, p = 0.18, respectively). On subgroup analyses, the response rates did not vary substantially and high heterogeneity persisted (I(2) = 57%–80%). Harmful outcomes were uncommon, and 5-NIs were associated with lower risk of abdominal pain, and higher risk of both bitter or metallic taste and headache. CONCLUSIONS: Studies investigating the efficacy of 5-NI in giardiasis treatment are highly heterogeneous. 5-NIs have a slightly better efficacy and worse profile for mild harmful outcomes in the treatment of giardiasis in comparison to controls. Larger high quality RCTs are needed to further assess efficacy and safety profiles of 5-NI